PSY30 COST-UTILITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) COMPARED WITH CORTICOSTEROIDS FOR THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) IN CANADA
Abstract
Authors
G Blackhouse F Xie K Gaebel D Robertson M Levine C Chalk N Assasi RA Goeree